Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT00832208
Previous Study | Return to List | Next Study

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

This study has been terminated.
Addis Ababa University
Information provided by (Responsible Party):
Drugs for Neglected Diseases Identifier:
First received: January 29, 2009
Last updated: January 20, 2016
Last verified: January 2016